Zhou_2023_J.Enzyme.Inhib.Med.Chem_38_2231661

Reference

Title : Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease - Zhou_2023_J.Enzyme.Inhib.Med.Chem_38_2231661
Author(s) : Zhou Y , He Y , Teng X , Mi J , Yang J , Wei R , Liu W , Ma Q , Tan Z , Sang Z
Ref : J Enzyme Inhib Med Chem , 38 :2231661 , 2023
Abstract : Zhou_2023_J.Enzyme.Inhib.Med.Chem_38_2231661
ESTHER : Zhou_2023_J.Enzyme.Inhib.Med.Chem_38_2231661
PubMedSearch : Zhou_2023_J.Enzyme.Inhib.Med.Chem_38_2231661
PubMedID: 37414563

Related information

Citations formats

Zhou Y, He Y, Teng X, Mi J, Yang J, Wei R, Liu W, Ma Q, Tan Z, Sang Z (2023)
Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease
J Enzyme Inhib Med Chem 38 :2231661

Zhou Y, He Y, Teng X, Mi J, Yang J, Wei R, Liu W, Ma Q, Tan Z, Sang Z (2023)
J Enzyme Inhib Med Chem 38 :2231661